Skip to main content

Mike Riyad

Analyst

Morgan Stanley

Equibles does not estimate personal net worth.

About Mike Riyad

Mike Riyad is recorded as Analyst at Morgan Stanley. Mike Riyad has spoken on 2 earnings calls across 2 companies, most recently for Jazz Pharmaceuticals plc on February 24, 2026. Those appearances were for Jazz Pharmaceuticals plc (JAZZ) and Alector, Inc. (ALEC). The companies whose calls Mike Riyad spoke on are classified in the Healthcare sector.

Mike Riyad on recent calls

“Are you able to provide any more color on the level of that modest step down on the HICMA royalty rate in 26 relative to last year? And then any commentary on the overall impact to the AG volume with two more generics coming on market?”
Analyst — Morgan Stanley, Jazz Pharmaceuticals plc Q4 FY2025 Earnings Call ·
“Thank you for taking our questions and congratulations on completing Enrollment for Progress. We have two questions. First one for Dr. Darby. We'd love to hear your thoughts.”
Analyst — Morgan Stanley, Alector, Inc. Q2 FY2025 Earnings Call ·

Affiliation history

  • Morgan Stanley

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity